The Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs

NEW YORK (AP) — Millions of older adults on Medicare prescription drug coverage could face steeper monthly costs in 2027, after the Trump administration concludes a temporary subsidy program that has helped offset premiums for the past two years. The Centers for Medicare & Medicaid Services this we...

Redirecting to full article...